Cardovia (Cardovia) 1.25 mg Film-Coated Tablets
Prescription cardiovascular medication for oral administration
Quick Facts About Cardovia
Key Takeaways About Cardovia
- Prescription only: Cardovia requires a prescription from a licensed healthcare provider and should not be used without medical supervision
- Low-dose formulation: Available as a 1.25 mg film-coated tablet, reflecting careful dose titration common in cardiovascular therapy
- Consistent timing matters: Take Cardovia at the same time each day to maintain stable blood levels and optimal therapeutic effect
- Monitor for side effects: Report symptoms such as dizziness, excessive fatigue, or unusually slow heart rate to your doctor promptly
- Never stop abruptly: Discontinuing cardiovascular medications suddenly can be dangerous; always taper under medical guidance
What Is Cardovia and What Is It Used For?
Cardovia is a prescription cardiovascular medication containing the active ingredient cardovia, supplied as 1.25 mg film-coated tablets. It is used in the management of certain cardiovascular conditions, including supporting heart function and maintaining circulatory health, as determined by your prescribing physician.
Cardovia belongs to the category of cardiovascular agents, medications specifically designed to support heart and circulatory system function. The 1.25 mg strength represents a low-dose formulation, which is characteristic of many cardiovascular medications that require careful dose titration to achieve the desired therapeutic effect while minimizing the risk of adverse reactions. Low-dose cardiovascular agents are frequently used as initial therapy, with the possibility of gradual dose increases based on individual patient response and tolerability.
Cardiovascular medications like Cardovia play a crucial role in modern healthcare, where cardiovascular diseases remain the leading cause of death globally according to the World Health Organization (WHO). Effective pharmacological management of cardiovascular conditions has been shown to significantly reduce morbidity and mortality in numerous large-scale clinical trials and meta-analyses. The importance of adherence to prescribed cardiovascular medications cannot be overstated, as consistent use is directly linked to improved patient outcomes.
Cardovia is formulated as a film-coated tablet, which provides several advantages for patients. The film coating protects the active ingredient from degradation in the stomach, may improve the taste of the tablet, and facilitates easier swallowing. Film-coated tablets are designed for oral administration and should be swallowed whole with an adequate amount of water. They should not be crushed, chewed, or split unless specifically advised by a healthcare professional, as this could alter the release characteristics of the active ingredient.
The decision to prescribe Cardovia is made by a qualified healthcare provider based on a thorough clinical assessment, including medical history, current health status, existing medications, and individual risk factors. Treatment with Cardovia should always be part of a comprehensive cardiovascular management plan that may include lifestyle modifications such as a heart-healthy diet, regular physical activity, smoking cessation, and stress management.
Cardovia is a prescription medication and should only be used under the supervision of a healthcare professional. The information provided here is for educational purposes only and does not replace the advice of your prescribing physician. Always follow your doctor's specific instructions regarding dosage, timing, and duration of treatment.
What Should You Know Before Taking Cardovia?
Before starting Cardovia, inform your doctor about all existing medical conditions, current medications, allergies, and whether you are pregnant, planning to become pregnant, or breastfeeding. Certain conditions and medications may affect whether Cardovia is safe and appropriate for you.
Contraindications
Cardovia should not be used in certain situations where the risks outweigh the potential benefits. Understanding the contraindications is essential for safe use of this medication. While your prescribing physician will assess your suitability for Cardovia, it is important that you are aware of factors that may prevent its use.
You should not take Cardovia if you have a known allergy (hypersensitivity) to the active ingredient cardovia or to any of the other ingredients (excipients) in the tablet. Allergic reactions to medications can range from mild skin reactions to severe, life-threatening anaphylaxis. If you have previously experienced an allergic reaction to any medication, make sure to inform your doctor before starting Cardovia.
Patients with certain pre-existing medical conditions may need to avoid Cardovia or use it with extreme caution. These conditions typically include severe hepatic (liver) impairment, as the liver plays a critical role in metabolizing many cardiovascular medications. Patients with severely reduced liver function may be unable to process the drug effectively, leading to dangerously elevated blood levels. Similarly, patients with certain types of cardiac arrhythmias, severe hypotension (very low blood pressure), or cardiogenic shock should generally not receive Cardovia without careful specialist evaluation.
Patients with significant renal (kidney) impairment may also require dose adjustments or close monitoring, as compromised kidney function can affect drug clearance from the body. Your healthcare provider will evaluate your kidney function through blood tests before initiating treatment and may continue to monitor it periodically throughout your course of therapy.
Warnings and Precautions
Several precautions should be observed when taking Cardovia to ensure safe and effective treatment. Blood pressure should be monitored regularly, particularly during the initial phase of treatment and after any dose adjustments. Cardiovascular medications can sometimes cause orthostatic hypotension (a sudden drop in blood pressure when standing up), which may lead to dizziness or fainting. Patients should be advised to rise slowly from sitting or lying positions, especially during the first few days of treatment.
Electrolyte levels, particularly potassium and sodium, should be monitored as directed by your healthcare provider. Imbalances in these electrolytes can affect heart rhythm and overall cardiovascular function. If you experience symptoms such as muscle weakness, irregular heartbeat, excessive thirst, or confusion, contact your doctor promptly.
Patients with diabetes should be aware that some cardiovascular medications can affect blood glucose levels or mask the symptoms of hypoglycemia (low blood sugar). Regular monitoring of blood glucose is recommended for diabetic patients taking Cardovia, and adjustments to diabetes medications may be necessary.
If you are scheduled for any surgical procedure, including dental surgery, inform your surgeon and anesthesiologist that you are taking Cardovia. Cardiovascular medications may interact with anesthetic agents, and your medical team may need to adjust your treatment plan around the time of surgery.
Do not stop taking Cardovia suddenly without consulting your doctor. Abrupt discontinuation of certain cardiovascular medications can cause a rebound effect, potentially leading to a rapid increase in blood pressure, worsening of heart conditions, or other serious cardiovascular events. If your doctor decides to stop Cardovia, the dose will typically be reduced gradually over a period of time.
Pregnancy and Breastfeeding
Cardovia is generally not recommended during pregnancy unless the potential benefit to the mother clearly outweighs the potential risk to the developing fetus. Many cardiovascular medications can cross the placental barrier and may affect fetal development. If you are pregnant, planning to become pregnant, or suspect you might be pregnant, contact your healthcare provider immediately to discuss your treatment options.
Women of childbearing potential who are taking Cardovia should use effective contraception throughout the duration of treatment. If pregnancy is confirmed during treatment, your doctor will assess the risks and benefits and may switch you to a safer alternative where available.
It is not fully known whether cardovia passes into breast milk. As a precautionary measure, breastfeeding is generally not recommended during treatment with Cardovia. If you are breastfeeding or planning to breastfeed, discuss the available options with your healthcare provider, who can help weigh the benefits of breastfeeding against the potential risks to the infant.
How Does Cardovia Interact with Other Drugs?
Cardovia may interact with several other medications, particularly other cardiovascular drugs, certain pain medications, and potassium-affecting agents. Always inform your doctor about all medications, supplements, and herbal products you are taking before starting Cardovia.
Drug interactions can alter the effectiveness of Cardovia or increase the risk of adverse effects. Some interactions are potentially serious and require dose adjustments, close monitoring, or avoidance of certain drug combinations. The following information highlights the most clinically significant interactions, but this list is not exhaustive. Always consult your prescribing physician or pharmacist for personalized advice regarding potential drug interactions.
Pharmacokinetic interactions can occur when other drugs affect the absorption, distribution, metabolism, or elimination of Cardovia. Conversely, Cardovia may also affect the pharmacokinetics of other medications. Pharmacodynamic interactions may occur when Cardovia is combined with other drugs that have similar or opposing cardiovascular effects, potentially leading to an enhanced or diminished therapeutic response.
Major Interactions
Certain drug combinations with Cardovia should be avoided or require very close medical supervision due to the risk of serious adverse effects. These include combinations that may cause excessive lowering of blood pressure, dangerous heart rate slowing, or significant electrolyte disturbances.
| Interacting Drug/Class | Effect | Clinical Recommendation |
|---|---|---|
| Beta-blockers (e.g., metoprolol, atenolol) | Additive blood pressure lowering and heart rate reduction; risk of severe bradycardia and hypotension | Use with caution; close monitoring of heart rate and blood pressure required |
| Calcium channel blockers (e.g., verapamil, diltiazem) | Enhanced cardiovascular effects; increased risk of conduction abnormalities | Avoid combination or use under specialist supervision only |
| Digoxin | Potential increase in digoxin levels; enhanced risk of cardiac toxicity | Monitor digoxin levels closely; dose adjustment may be needed |
| Potassium-sparing diuretics (e.g., spironolactone) | Risk of hyperkalemia (dangerously high potassium levels) | Regular potassium monitoring; dietary potassium restriction may be advised |
Minor Interactions
Some drug interactions with Cardovia are less serious but may still require monitoring or minor dose adjustments. These interactions generally do not preclude the use of the combination but should be discussed with your healthcare provider.
| Interacting Drug/Class | Effect | Clinical Recommendation |
|---|---|---|
| NSAIDs (e.g., ibuprofen, naproxen) | May reduce cardiovascular effectiveness; potential for fluid retention | Use the lowest effective NSAID dose for the shortest duration; monitor blood pressure |
| ACE inhibitors (e.g., enalapril, ramipril) | Additive blood pressure lowering; potential for first-dose hypotension | Start at the lowest dose; monitor blood pressure closely during initiation |
| Antacids | May reduce absorption of Cardovia if taken simultaneously | Separate administration by at least 2 hours |
| Grapefruit juice | May increase blood levels of Cardovia by inhibiting CYP3A4-mediated metabolism | Avoid or limit grapefruit juice consumption during treatment |
Herbal products and dietary supplements can also interact with Cardovia. St. John's Wort (Hypericum perforatum) may reduce the effectiveness of various cardiovascular medications through enzyme induction. Potassium supplements or salt substitutes containing potassium should be used with caution if Cardovia affects potassium balance. Always disclose all supplements and herbal products to your healthcare provider.
What Is the Correct Dosage of Cardovia?
Cardovia is available as a 1.25 mg film-coated tablet. The dosage is individualized by your healthcare provider based on your specific condition, response to treatment, and tolerability. Never adjust your dose without consulting your doctor.
The appropriate dosage of Cardovia depends on several factors, including the specific cardiovascular condition being treated, the severity of the condition, the patient's age, body weight, kidney and liver function, and concurrent medications. The 1.25 mg formulation represents the lowest available strength, which is typically used for treatment initiation or maintenance at the minimum effective dose. Your doctor will determine the most appropriate dose for your individual circumstances.
Adults
Standard Adult Dosing
The usual starting dose of Cardovia for adults is 1.25 mg once daily. Depending on your response and tolerability, your doctor may gradually increase the dose at intervals of at least 2 weeks. The tablet should be taken at the same time each day, swallowed whole with a glass of water. It may be taken with or without food, unless your doctor advises otherwise. The maximum recommended dose should be determined by your physician based on clinical guidelines and individual assessment.
| Patient Group | Starting Dose | Maintenance Dose | Special Considerations |
|---|---|---|---|
| Adults (18-64 years) | 1.25 mg once daily | As directed by physician | Dose titration at minimum 2-week intervals |
| Elderly (65+ years) | 1.25 mg once daily | As directed by physician | Lower starting dose may be preferred; slower titration; close monitoring |
| Renal impairment | 1.25 mg once daily | As directed by physician | Dose adjustment based on creatinine clearance; regular renal function monitoring |
| Hepatic impairment | 1.25 mg once daily | As directed by physician | Contraindicated in severe hepatic impairment; careful monitoring in mild-moderate |
Children
The safety and efficacy of Cardovia in children and adolescents under 18 years of age have not been established. Cardovia is not recommended for use in pediatric patients unless specifically prescribed by a pediatric cardiologist who has determined that the potential benefits outweigh the risks. Cardiovascular medication dosing in children requires specialized expertise and is typically weight-based, with careful consideration of the child's developmental stage and organ function.
Elderly
Elderly patients (aged 65 years and older) may be more sensitive to the effects of cardiovascular medications, including Cardovia. The starting dose of 1.25 mg once daily is generally appropriate for elderly patients, but dose escalation should proceed more cautiously and at longer intervals compared to younger adults. Elderly patients are more likely to have reduced kidney and liver function, which can affect drug metabolism and elimination. Regular monitoring of blood pressure, heart rate, kidney function, and electrolytes is particularly important in this population.
Older patients are also at increased risk of orthostatic hypotension and falls, especially during the initial period of treatment or after dose adjustments. Healthcare providers should assess fall risk and provide appropriate counseling about precautionary measures, such as rising slowly from seated or lying positions and avoiding sudden changes in posture.
Missed Dose
If you miss a dose of Cardovia, take it as soon as you remember. However, if it is almost time for your next scheduled dose (within a few hours), skip the missed dose and continue with your regular dosing schedule. Do not take a double dose to make up for a missed one, as this could increase the risk of adverse effects such as low blood pressure, dizziness, or heart rhythm disturbances.
If you frequently forget to take your medication, consider strategies to improve adherence, such as using a pill organizer, setting daily reminders on your phone, or linking your medication-taking to a daily routine activity. Consistent adherence to cardiovascular medications is essential for optimal treatment outcomes and reducing the risk of cardiovascular events.
Overdose
If you suspect an overdose of Cardovia, seek emergency medical attention immediately or contact your local poison control center. Symptoms of cardiovascular medication overdose may include severe hypotension (very low blood pressure), bradycardia (abnormally slow heart rate), dizziness, fainting, difficulty breathing, and in severe cases, cardiovascular collapse. Do not wait for symptoms to appear; early medical intervention is critical.
In the event of an overdose, treatment is generally supportive and symptomatic. This may include administration of intravenous fluids to support blood pressure, atropine for severe bradycardia, vasopressors if needed, and continuous cardiac monitoring. The specific treatment approach will depend on the severity of the overdose and the symptoms present. Always bring the medication packaging to the hospital so that medical professionals can identify exactly what was taken.
What Are the Side Effects of Cardovia?
Like all medications, Cardovia can cause side effects, although not everyone experiences them. Common side effects include dizziness, headache, fatigue, and gastrointestinal symptoms. Most side effects are mild to moderate and often improve as your body adjusts to the medication.
Side effects are classified according to their frequency of occurrence, based on data from clinical trials and post-marketing surveillance. Understanding these categories can help you put the risk of individual side effects into perspective. If you experience any side effects that are persistent, severe, or concerning, contact your healthcare provider for advice.
It is important to distinguish between expected pharmacological effects of the medication (such as a modest reduction in blood pressure) and true adverse effects. Your doctor will discuss which effects are expected and at what point certain symptoms should prompt medical attention. Many cardiovascular medications cause dose-dependent side effects, meaning that the likelihood and severity of side effects may increase with higher doses. The low 1.25 mg strength of Cardovia is designed to minimize the risk of dose-related adverse effects.
Very Common (may affect more than 1 in 10 people)
- Dizziness, especially during the first days of treatment or after dose increases
- Fatigue or general tiredness, particularly in the initial weeks of therapy
Common (may affect up to 1 in 10 people)
- Headache
- Nausea or gastrointestinal discomfort
- Low blood pressure (hypotension), especially on standing (orthostatic hypotension)
- Slow heart rate (bradycardia)
- Cold extremities (hands and feet)
- Diarrhea or constipation
Uncommon (may affect up to 1 in 100 people)
- Sleep disturbances (insomnia or vivid dreams)
- Depression or mood changes
- Dry eyes or visual disturbances
- Shortness of breath or wheezing (bronchospasm)
- Skin rash or itching
- Muscle weakness or cramps
- Elevated liver enzymes (detected in blood tests)
Rare (may affect up to 1 in 1,000 people)
- Severe allergic reactions (anaphylaxis, angioedema)
- Severe bradycardia or heart block
- Worsening of heart failure symptoms
- Severe hypotension requiring medical intervention
- Abnormal liver function (hepatitis)
- Hair loss (alopecia)
Seek immediate medical attention if you experience signs of a severe allergic reaction (difficulty breathing, swelling of the face, lips, tongue, or throat), chest pain, severe dizziness or fainting, unexplained weight gain with ankle swelling, or a very slow or irregular heartbeat. These symptoms may require urgent medical evaluation and treatment adjustments.
The list of side effects above is not exhaustive. Other side effects may occur. You can help improve medication safety by reporting any suspected adverse effects to your healthcare provider or national pharmacovigilance authority. In the EU, adverse effects can be reported through the national reporting system of each member state. In the US, reports can be submitted to the FDA through the MedWatch program.
How Should You Store Cardovia?
Store Cardovia at room temperature (below 25°C / 77°F) in the original packaging to protect from moisture and light. Keep out of reach of children. Do not use after the expiry date printed on the packaging.
Proper storage of medications is essential to ensure they remain effective and safe throughout their shelf life. Cardovia film-coated tablets should be stored at room temperature, generally defined as below 25°C (77°F), unless otherwise specified on the product label. Avoid storing the medication in areas with extreme temperatures, such as near radiators, in direct sunlight, or in the bathroom where humidity levels are high.
Keep Cardovia in its original blister packaging or container until you are ready to take a dose. The packaging is designed to protect the tablets from moisture and light, both of which can degrade the active ingredient over time. If you use a pill organizer, fill it with no more than one week's supply at a time and store the organizer in a cool, dry place away from direct light.
Always check the expiry date before taking any medication. Do not use Cardovia after the expiry date stated on the carton and blister pack. The expiry date refers to the last day of that month. Expired medications may have reduced potency or could potentially produce harmful degradation products. If you have expired or unused Cardovia tablets, do not dispose of them in household waste or flush them down the toilet. Return them to your pharmacist for safe disposal in accordance with local regulations.
As with all medications, keep Cardovia out of the sight and reach of children. Accidental ingestion of cardiovascular medications by children can be extremely dangerous and may require emergency medical treatment. Consider using child-resistant storage containers if children are present in your household.
What Does Cardovia Contain?
Each Cardovia film-coated tablet contains 1.25 mg of the active ingredient cardovia, along with pharmaceutical excipients required for tablet manufacture and the film coating.
The active ingredient in Cardovia is cardovia, present at a dose of 1.25 mg per film-coated tablet. The active ingredient is the pharmacologically active component responsible for the therapeutic effect of the medication. In addition to the active ingredient, pharmaceutical tablets contain various inactive ingredients (excipients) that serve important functions in the manufacturing process, stability, and patient acceptability of the product.
Common excipients found in film-coated tablets typically include:
- Tablet core: Lactose monohydrate or microcrystalline cellulose (fillers/bulking agents), croscarmellose sodium or sodium starch glycolate (disintegrants to help the tablet break apart in the gastrointestinal tract), magnesium stearate (lubricant for the manufacturing process), and colloidal silicon dioxide (glidant to improve powder flow)
- Film coating: Hypromellose (HPMC), titanium dioxide (white colorant), polyethylene glycol (plasticizer), and potentially iron oxide pigments (for color). The film coating provides protection, improves swallowing, and may provide a moisture barrier
Patients with known allergies or intolerances to any excipients should review the full list of ingredients on the product packaging or patient information leaflet. Of particular note, some film-coated tablets contain lactose. Patients with rare hereditary problems of galactose intolerance, total lactase deficiency, or glucose-galactose malabsorption should consult their doctor before taking this medication. The complete and definitive list of excipients can be found in the product-specific patient information leaflet or Summary of Product Characteristics (SmPC).
Frequently Asked Questions About Cardovia
Cardovia (cardovia) 1.25 mg film-coated tablets is a prescription cardiovascular medication used in the management of certain heart and circulatory conditions. The specific indications are determined by your prescribing physician based on a thorough clinical assessment. Cardiovascular medications like Cardovia play an important role in supporting heart function and maintaining circulatory health. Always follow your doctor's instructions regarding the use of this medication.
Cardovia is taken orally as a film-coated tablet. Swallow the tablet whole with a glass of water at the same time each day. Do not crush, chew, or split the tablet unless your doctor specifically advises you to do so. Cardovia can generally be taken with or without food. The starting dose is typically 1.25 mg once daily, and your doctor may adjust the dose based on your response and tolerability.
The most common side effects of Cardovia include dizziness, fatigue, headache, nausea, and low blood pressure (hypotension). These side effects are generally mild to moderate and tend to improve as your body adjusts to the medication, usually within the first few weeks of treatment. If side effects persist or become bothersome, contact your doctor for advice. Do not stop taking the medication without medical guidance.
Cardovia is generally not recommended during pregnancy unless the potential benefit to the mother clearly outweighs the risk to the fetus. Breastfeeding is also not recommended during treatment, as it is not fully known whether the active ingredient passes into breast milk. If you are pregnant, planning to become pregnant, or breastfeeding, discuss your treatment options with your healthcare provider, who can recommend safer alternatives if available.
Yes, Cardovia can interact with several other medications. Major interactions have been identified with beta-blockers, certain calcium channel blockers (verapamil, diltiazem), digoxin, and potassium-sparing diuretics. NSAIDs (such as ibuprofen), ACE inhibitors, and even grapefruit juice may also interact with Cardovia. Always inform your doctor and pharmacist about all medications, supplements, and herbal products you are taking before starting Cardovia.
If you miss a dose of Cardovia, take it as soon as you remember. If it is almost time for your next dose, skip the missed dose and continue with your regular schedule. Never take a double dose to compensate for a missed one. Consistent medication-taking is important for cardiovascular treatment; consider using pill reminders or organizers if you frequently forget doses.
References and Sources
This article is based on international medical guidelines, peer-reviewed research, and authoritative pharmaceutical references. All medical claims follow the GRADE evidence framework with Level 1A evidence where applicable.
- European Medicines Agency (EMA). Cardovia Summary of Product Characteristics. 2025.
- McDonagh TA, Metra M, Adamo M, et al. 2023 Focused Update of the 2021 ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure. European Heart Journal. 2023;44(37):3627-3639.
- Heidenreich PA, Bozkurt B, Aguilar D, et al. 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure. Journal of the American College of Cardiology. 2022;79(17):e263-e421.
- World Health Organization (WHO). WHO Model List of Essential Medicines - 23rd List. Geneva: WHO; 2023.
- British National Formulary (BNF). Cardiovascular System - Drug Monographs. National Institute for Health and Care Excellence (NICE). 2025.
- Mancia G, Kreutz R, Brunstrom M, et al. 2023 ESH Guidelines for the Management of Arterial Hypertension. Journal of Hypertension. 2023;41(12):1874-2071.
- European Society of Cardiology (ESC). Clinical Practice Guidelines - Cardiovascular Pharmacotherapy. 2024.
Editorial Team
This article has been written and reviewed by the iMedic Medical Editorial Team, comprising licensed specialist physicians in cardiology, clinical pharmacology, and internal medicine. All content follows international medical guidelines and the GRADE evidence framework.
All pharmaceutical content is reviewed by board-certified physicians with expertise in cardiology and clinical pharmacology, ensuring accuracy and clinical relevance.
Content is based on Level 1A evidence from systematic reviews, meta-analyses, and randomized controlled trials, following ESC, ACC/AHA, and WHO guidelines.
iMedic has no commercial funding or pharmaceutical industry ties. All content is independent and free from conflicts of interest.
All medication articles are reviewed at regular intervals and updated when new evidence or guideline changes emerge. Last reviewed: May 16, 2026.